Understanding Variability in CAR-T Cell Therapy Kinetics Publication Understanding Variability in CAR-T Cell Therapy Kinetics Axicabtagene ciloleucel (axi-cel), a CAR-T cell therapy for relapsed and refractory non-Hodgkin’s lymphoma (NHL), demonstrates…Certara2025年1月23日
Model-informed drug discovery and development approaches to inform clinical trial design and regulatory decisions: A primer for the MENA region Publication Model-informed drug discovery and development approaches to inform clinical trial design and regulatory decisions: A primer for the MENA region The integration of MID3 offers a transformative opportunity for the MENA region to advance pharmaceutical…Certara2025年1月14日
Solving Drug Development Challenges with Model-Based Meta-Analysis (MBMA) On-Demand Webinar Solving Drug Development Challenges with Model-Based Meta-Analysis (MBMA) In this on-demand webinar, "MBMA: Optimizing Drug Development with Aggregate Clinical Trial Data and Predictive…Certara2025年1月9日
From Research to Real-World Impact: A Model Informed Drug Development (MIDD) Framework to Support Understudied Populations On-Demand Webinar From Research to Real-World Impact: A Model Informed Drug Development (MIDD) Framework to Support Understudied Populations SVP, Client and Regulatory Strategy, Certara Dr. Karen Rowland Yeo is Senior Vice-President, Client &…Certara2025年1月3日
Population Pharmacokinetics (PopPK) of Revumenib in Patients with Relapsed/Refractory Acute Leukemias Poster Population Pharmacokinetics (PopPK) of Revumenib in Patients with Relapsed/Refractory Acute Leukemias Certara2024年12月12日
Piet van der Graaf on AI and AI-assisted approaches in drug discovery & development Video Piet van der Graaf on AI and AI-assisted approaches in drug discovery & development At the 2024 AAPS PharmSci 360 conference, Bioanalysis Zone interviewed Piet van der Graaf, Senior…Certara2024年12月10日
Advancing pharmacometrics in Africa – Transition from capacity development toward job creation Publication Advancing pharmacometrics in Africa – Transition from capacity development toward job creation This CPT article showcases, the Applied Pharmacometrics Training (APT) program, launched in 2021 by Pharmacometrics…Certara2024年12月9日
Forbes: Adoption Of Model-Informed Drug Development Can Improve Pharma ROI Press Coverage Forbes: Adoption Of Model-Informed Drug Development Can Improve Pharma ROI Published: 2024年11月27日 Recent decades have seen continuing declines in pharmaceutical R&D productivity. Inflation…Certara2024年11月27日
Population K-PD Modeling of Plozasiran (ARO-APOC3), a GalNAc-siRNA Conjugate, for the Treatment of Patients with Severe Hypertriglyceridemi Poster Population K-PD Modeling of Plozasiran (ARO-APOC3), a GalNAc-siRNA Conjugate, for the Treatment of Patients with Severe Hypertriglyceridemi Certara2024年11月22日
Population pharmacokinetic modeling of TBA-7371 in healthy participants describes apparent auto-induction of clearance and predicts PK in participants with Mycobacterium tuberculosis. ポスター Population pharmacokinetic modeling of TBA-7371 in healthy participants describes apparent auto-induction of clearance and predicts PK in participants with Mycobacterium tuberculosis. Certara2024年11月22日